News Headlines Article

Medicare will keep covering Roche’s Avastin
Health Key

Medicare will continue paying for Roche Holding’s drug Avastin for breast cancer, regardless of what health regulators decide about the medicine’s future, a spokesman said on Thursday.

The statement from the U.S. healthcare program could mitigate concerns that patients using the drug would lose insurance coverage should the U.S. Food and Drug Administration revoke approval for its use in breast cancer.